Clinical and Vaccine Immunology 2012-10-01

Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.

Christopher B Fox, Susan L Baldwin, Thomas S Vedvick, Evelina Angov, Steven G Reed

Index: Clin. Vaccine Immunol. 19(10) , 1633-40, (2012)

Full Text: HTML

Abstract

New malaria vaccines are urgently needed to improve vaccine protective efficacy. PfCelTOS is a recombinant malaria vaccine antigen that has shown protective efficacy in a small-animal challenge model when combined with a water-in-oil emulsion adjuvant (Montanide ISA 720). In this report, we show that PfCelTOS vaccines containing GLA-SE (a stable oil-in-water emulsion combined with a Toll-like receptor 4 [TLR4] agonist) elicit strong Th1-type immune responses in BALB/c mice. These responses include higher antigen-specific IgG2a antibody titers and more gamma interferon (IFN-γ) production than those seen with a PfCelTOS vaccine containing Montanide ISA 720. Furthermore, reducing the emulsion dose from 2% to 1% or 0.5% (vol/vol) squalene in GLA-SE did not compromise immunogenicity. Emulsion dose titration in the absence of formulated GLA caused some reduction in humoral and cellular immune responses compared to those with the 2% squalene emulsion dose.

Related Compounds

Related Articles:

Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.

2009-08-06

[Vaccine 27(36) , 5020-5, (2009)]

Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults.

2010-03-02

[Vaccine 28(10) , 2236-42, (2010)]

Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.

2010-01-01

[PLoS ONE 5(8) , e12294, (2010)]

Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.

2010-07-01

[J. Virol. Methods 167(1) , 10-6, (2010)]

CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.

2011-10-19

[Vaccine 29(45) , 7960-5, (2011)]

More Articles...